Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Anesthetics: Chemistry and Structure-Activity Relationship01:30

Local Anesthetics: Chemistry and Structure-Activity Relationship

6.4K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
6.4K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

921
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
921
Molecular Models02:00

Molecular Models

43.5K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.5K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.0K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of potential 3CLpro inhibitors-modulators for human norovirus infections through an advanced virtual screening approach.

Journal of biomolecular structure & dynamics·2025
Same author

Precision targeting of fat metabolism in triple negative breast cancer with a biotinylated copolymer.

Journal of materials chemistry. B·2024
Same author

Structure-guided screening of protein-protein interaction for the identification of Myc-Max heterodimer complex modulators.

Journal of biomolecular structure & dynamics·2023
Same author

Investigation of bio-active Amaryllidaceae alkaloidal small molecules as putative SARS-CoV-2 main protease and host TMPRSS2 inhibitors: interpretation by <i>in-silico</i> simulation study.

Journal of biomolecular structure & dynamics·2023
Same author

Coomassie brilliant blue G-250 acts as a potential chemical chaperone to stabilize therapeutic insulin.

Chemical communications (Cambridge, England)·2023
Same author

Drug repurposing against the RNA-dependent RNA polymerase domain of dengue serotype 3 by virtual screening and molecular dynamics simulations.

Journal of biomolecular structure & dynamics·2022

Related Experiment Video

Updated: Jan 17, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

Exploring molecular structural requirement for AChE inhibition through multi-chemometric and dynamics simulation

Tabassum Hossain1, Achintya Saha1, Arup Mukherjee1

  • 1a Department of Chemical Technology , University of Calcutta , 92, A. P. C. Road, Kolkata , 700009 , India.

Journal of Biomolecular Structure & Dynamics
|April 19, 2017
PubMed
Summary

This study identifies key molecular features for inhibiting acetylcholinesterase (AChE), crucial for preventing acetylcholine depletion and potentially slowing amyloid plaque deposition in neurodegenerative diseases.

Keywords:
CoMFACoMSIAHQSARacetylcholinesterasemolecular dynamicspharmacophore mapping

More Related Videos

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

833

Related Experiment Videos

Last Updated: Jan 17, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.2K
Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
05:57

Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function

Published on: April 26, 2024

833

Area of Science:

  • Medicinal Chemistry
  • Computational Biology
  • Neuroscience

Background:

  • Acetylcholinesterase (AChE) regulates acetylcholine (ACh) levels, impacting central and peripheral nervous systems.
  • AChE activity is implicated in accelerating amyloid β-peptide (Aβ) plaque deposition, a hallmark of senile conditions.
  • Inhibiting AChE is a therapeutic strategy to prevent ACh depletion.

Purpose of the Study:

  • To explore ligand- and structure-based computational methods for optimizing AChE inhibitors.
  • To identify critical structural and physicochemical properties for selective AChE binding and enzyme inhibition.
  • To develop predictive models for designing novel AChE inhibitors with therapeutic benefits and reduced toxicity.

Main Methods:

  • Utilized 3D Quantitative Structure-Activity Relationship (QSAR) studies, including CoMFA and CoMSIA.
  • Employed 3D QSAR (HQSAR), pharmacophore modeling, molecular docking, and simulation techniques.
  • Applied both ligand-based and structure-based approaches to a diverse set of AChE inhibitors.

Main Results:

  • Pharmacophore modeling highlighted the importance of hydrogen bond acceptors/donors, positive ionization, and hydrophobic features for binding.
  • Docking and simulation studies validated features identified by QSAR, HQSAR, and pharmacophore models.
  • Developed predictive models (CoMFA, CoMSIA, HQSAR, pharmacophore) with high statistical significance (e.g., Q² values ranging from 0.608 to 0.850).

Conclusions:

  • Identified essential structural and physicochemical profiles for effective and selective AChE inhibition.
  • The developed computational models demonstrate broad applicability for designing novel therapeutic agents.
  • This research provides a foundation for developing new treatments targeting AChE-related conditions with improved safety profiles.